Neurocrine Biosciences, Inc. (NBIX) DCF Valuation

Neurocrine Biosciences, Inc. (NBIX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Neurocrine Biosciences, Inc. (NBIX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Save time and improve precision with our (NBIX) DCF Calculator! With access to real Neurocrine Biosciences data and customizable assumptions, this tool empowers you to forecast, analyze, and value Neurocrine Biosciences like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 788.1 1,045.9 1,133.5 1,488.7 1,887.1 2,033.8 2,191.9 2,362.2 2,545.8 2,743.7
Revenue Growth, % 0 32.71 8.38 31.34 26.76 7.77 7.77 7.77 7.77 7.77
EBITDA 226.6 336.1 218.7 264.6 358.0 475.6 512.6 552.4 595.4 641.6
EBITDA, % 28.75 32.14 19.29 17.77 18.97 23.39 23.39 23.39 23.39 23.39
Depreciation 7.5 8.6 10.9 15.6 21.3 20.0 21.5 23.2 25.0 26.9
Depreciation, % 0.94557 0.82226 0.96162 1.05 1.13 0.98121 0.98121 0.98121 0.98121 0.98121
EBIT 219.1 327.5 207.8 249.0 336.7 455.7 491.1 529.2 570.4 614.7
EBIT, % 27.81 31.31 18.33 16.73 17.84 22.4 22.4 22.4 22.4 22.4
Total Cash 670.5 801.0 711.3 989.3 1,031.6 1,405.5 1,514.7 1,632.5 1,759.4 1,896.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 126.6 157.1 185.5 350.0 439.3
Account Receivables, % 16.06 15.02 16.37 23.51 23.28
Inventories 17.3 28.0 30.5 35.1 38.3 48.6 52.4 56.5 60.8 65.6
Inventories, % 2.19 2.68 2.69 2.36 2.03 2.39 2.39 2.39 2.39 2.39
Accounts Payable 41.4 39.4 51.5 67.3 108.9 97.0 104.6 112.7 121.5 130.9
Accounts Payable, % 5.25 3.77 4.54 4.52 5.77 4.77 4.77 4.77 4.77 4.77
Capital Expenditure -14.7 -10.9 -23.4 -16.5 -28.3 -30.9 -33.3 -35.8 -38.6 -41.6
Capital Expenditure, % -1.87 -1.04 -2.06 -1.11 -1.5 -1.52 -1.52 -1.52 -1.52 -1.52
Tax Rate, % 24.81 24.81 24.81 24.81 24.81 24.81 24.81 24.81 24.81 24.81
EBITAT 174.4 1,250.1 183.6 179.9 253.2 378.5 407.9 439.6 473.8 510.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 64.6 1,204.6 152.3 25.7 195.3 401.4 370.2 398.9 429.9 463.3
WACC, % 6.04 6.07 6.05 6.03 6.03 6.04 6.04 6.04 6.04 6.04
PV UFCF
SUM PV UFCF 1,727.7
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 482
Terminal Value 23,567
Present Terminal Value 17,574
Enterprise Value 19,301
Net Debt 177
Equity Value 19,124
Diluted Shares Outstanding, MM 101
Equity Value Per Share 189.35

What You Will Get

  • Real NBIX Financials: Access to historical and projected data for precise valuation.
  • Adjustable Inputs: Tailor WACC, tax rates, revenue growth, and capital expenditures to your needs.
  • Automatic Calculations: Dynamic computation of intrinsic value and NPV.
  • Scenario Analysis: Evaluate multiple scenarios to assess Neurocrine’s future performance.
  • Clear and Intuitive Design: Designed for professionals while remaining user-friendly for newcomers.

Key Features

  • Real-Time NBIX Data: Pre-loaded with Neurocrine Biosciences' historical financials and future projections.
  • Customizable Assumptions: Modify revenue growth rates, profit margins, discount rates, tax implications, and capital investments.
  • Interactive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on user-defined inputs.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • Intuitive Interface: Designed for ease of use, catering to both seasoned professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Neurocrine Biosciences data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Neurocrine Biosciences’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Neurocrine Biosciences, Inc. (NBIX)?

  • User-Friendly Interface: Tailored for both novice and seasoned users.
  • Customizable Inputs: Adjust assumptions easily to suit your analytical needs.
  • Real-Time Updates: Monitor immediate changes in Neurocrine's valuation as you tweak inputs.
  • Preloaded Data: Comes with Neurocrine’s actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Professionals: Understand the intricacies of drug development and market analysis for Neurocrine Biosciences (NBIX).
  • Researchers: Utilize advanced models to incorporate Neurocrine's innovative therapies into studies and publications.
  • Investors: Evaluate your investment strategies and assess the potential of Neurocrine Biosciences (NBIX) in the biotech sector.
  • Market Analysts: Enhance your reports with a customizable framework for analyzing Neurocrine's financial performance.
  • Pharmaceutical Entrepreneurs: Gain valuable insights into how established biotech companies like Neurocrine Biosciences (NBIX) navigate the market.

What the Template Contains

  • Pre-Filled Data: Includes Neurocrine Biosciences' historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Neurocrine Biosciences' profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.